Fizyhealth
The Rx Spot company profile

The Rx Spot company profile: what is public, what is not

The Rx Spot is a B2B telehealth operations platform at therxspot.com that gives healthcare operators white-label patient storefronts, a bundled 50-state licensed provider network, and fulfillment routing through 503A and 503B compounding partners. The platform's product, model, and catalog are publicly documented. Ownership, leadership, funding history, headquarters, and customer counts are not disclosed on the public site as of June 2026.

If you are doing vendor due diligence on The Rx Spot as a company before signing an operator agreement, this page separates the publicly verifiable product facts from the corporate details The Rx Spot does not disclose — without filling the gaps with guesses.

Compare Fizy Health vs The Rx Spot

Proudly Partnered With

What is publicly verifiable about The Rx Spot?

What can be verified from The Rx Spot's public materials is the product and its model. The Rx Spot is a B2B telehealth operations platform at therxspot.com that gives healthcare operators white-label patient storefronts — custom domain, patient intake, checkout, and provider review — plus a marketplace dashboard for catalog and retail pricing control, a staff ops portal for order fulfillment and patient operations, a bundled 50-state licensed provider network, and fulfillment routing through 503A and 503B compounding pharmacy partners. The catalog spans GLP-1s, peptides, hair, skin, longevity, and over 1,400 generics. What is not on the public site as of June 2026 is corporate detail: ownership, leadership, funding history, headquarters address, and operator or order counts are not disclosed publicly.

Who needs this company profile

Due diligence falls to the roles signing the operator agreement.

A company profile matters most to the roles responsible for vendor risk before a business commits to building on The Rx Spot's infrastructure. Three of them carry that weight.

  • Brand Builders

    Founders whose brand depends on platform continuity.

    Operators building a telehealth brand on The Rx Spot's storefront infrastructure have meaningful continuity risk if the platform changes or closes. Founders need to know what can be confirmed about The Rx Spot's stability and corporate standing, and what to negotiate in the operator agreement to protect the brand if the platform relationship changes.

  • Clinic and Medspa Owners

    Practice owners assessing vendor reliability.

    Clinic and medspa owners who add The Rx Spot as a commerce channel for their practice evaluate company stability alongside product fit. Because customer counts and financial details are undisclosed, they assess reliability through direct references, contract terms, and the responsiveness of the demo and support process rather than published metrics.

  • Compliance Officers

    Compliance leads verifying the partner pharmacy chain.

    Compliance officers and prescribers want assurance that The Rx Spot routes to legitimately licensed 503A and 503B compounding pharmacies. Since The Rx Spot does not publish its specific partner pharmacy list on the public site, their due diligence centers on requesting proof of partner licensure and LegitScript certification for the specific compounders that would fulfill their operator's orders.

What The Rx Spot publishes and what it does not

The Rx Spot's public site documents the product clearly: three surfaces (patient storefront, marketplace dashboard, staff ops portal), the bundled 50-state provider network, 503A and 503B compounding fulfillment, and a catalog of over 1,400 medications including GLP-1s, peptides, hair, skin, longevity, and generics. The Ready Pro Nutrition supplement line partnership is also mentioned as an add-on for operators. The site routes interested parties to a demo request and provides messaging about platform capabilities. What the site does not publish, as of June 2026, is any corporate detail: there is no named leadership, no listed investors, no disclosed headquarters, and no operator or order count.

This is common for privately held B2B platforms in the healthcare commerce space and is not by itself a disqualifying signal. But it does mean a due diligence process must come from direct requests — questions asked in the sales and onboarding conversation — rather than from publicly available filings or the company website.

What to confirm directly with The Rx Spot

Because corporate facts are not public, request them explicitly: ask which legal entity the operator agreement is with, who stands behind the platform and its continuity, and how long The Rx Spot has operated in its current form. Ask for the specific 503A and 503B partner pharmacies your storefront would route to — by name — and request proof of their LegitScript certification and state licensure. Ask for references from operators in a similar vertical — telehealth brands, clinics, or wellness operators — and review the contract terms carefully, including exit provisions and what happens to your brand's storefront data and domain if the operator agreement ends.

For the product facts the site does document, Fizy Health provides a transparent comparison point: pass-through per-vial 503A pricing shown before checkout, a disclosed facilitation fee, LegitScript-certified partner pharmacies, a BAA at onboarding, and self-serve signup without a demo requirement. When a vendor's corporate details are thin, the best calibration is to compare what each platform publicly commits to on the product side.

After due diligence — which platform fits your operation?

The Rx Spot fits if

The Rx Spot

Launch a telehealth brand. Storefront, providers, and fulfillment bundled.

  • You are launching a new telehealth or wellness brand and need a white-label patient storefront with intake and checkout.
  • You want a bundled 50-state provider network and compounding partners behind one operator dashboard.
  • You prefer setting tiered retail pricing on a DTC storefront over batching in-office clinic orders.
Consider Fizy Health if

Fizy Health

One cart for every patient today. Every pharmacy. One checkout.

  • You already prescribe and need one session to batch today's GLP-1, hormone, and peptide refills — not a new patient storefront.
  • You want pass-through per-vial 503A cost visible before you quote cash-pay patients or submit payment.
  • You use more than one 503A partner and want routing and tracking from one login instead of portal hopping.
If you choose Fizy Health

What your clinic gets from a transparent pass-through platform.

If your clinic already prescribes and needs batch checkout with visible per-vial cost — not a vendor's corporate opacity — these are the outcomes Fizy Health delivers.

See all features
Keep evaluating The Rx Spot

More answers in the The Rx Spot evaluation guide.

See the full The Rx Spot guide
FAQ

Company questions operators ask about The Rx Spot.

  • Company

    What is The Rx Spot as a company?

    The Rx Spot is a B2B telehealth operations platform at therxspot.com that gives healthcare operators white-label patient storefronts, a bundled 50-state licensed provider network, and fulfillment routing through 503A and 503B compounding partners. That product and model are publicly verifiable; broader corporate details — ownership, funding, leadership — are not published on the site as of June 2026.

  • Ownership

    Who owns The Rx Spot?

    The Rx Spot does not publish ownership or leadership information on therxspot.com as of June 2026. If ownership matters to your due diligence, ask which legal entity the operator agreement is with during the sales and onboarding conversation.

  • Funding

    Has The Rx Spot raised funding?

    The Rx Spot does not disclose funding history on its public site as of June 2026. There is no verifiable public record to cite here, so this profile reports it as undisclosed rather than speculate about investors or amounts.

  • Customers

    How many operators use The Rx Spot?

    The Rx Spot does not publish operator or order counts as of June 2026. Rather than cite an invented number, ask The Rx Spot directly for references from operators in a similar vertical — telehealth brands, clinics, or wellness businesses — and for a live storefront example you can review.

  • Diligence

    What should I confirm before signing with The Rx Spot?

    Confirm the legal entity you are contracting with, the specific 503A and 503B partner pharmacies your storefront would route to and their licensure and LegitScript certification, references from comparable operators, and the contract terms including exit provisions and what happens to your brand's data and domain if the operator relationship ends.

  • Alternative

    How transparent is Fizy Health by comparison?

    Fizy Health publishes its model openly: pass-through per-vial 503A pricing shown in catalog and cart before checkout, a disclosed facilitation fee at payment, LegitScript-certified 503A partner pharmacies, a BAA at onboarding, and self-serve signup without a demo requirement. When evaluating vendors, the product commitments each makes publicly are the most comparable signal.

Sources reviewed June 2026

  • The Rx Spot public website, product pages, and FAQ (therxspot.com), reviewed June 2026. Ownership, funding, and customer counts are not disclosed on the public site as of this date.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Choose a platform that shows its model up front.

See how Fizy Health shows landed cost before you quote, validates orders before you pay, and routes your clinic cart across assigned 503A partners. Free to start.

Fizy Health vs The Rx SpotStart Ordering Free